Clinical trial
A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab…
NCT01287741 · Hoffmann-La Roche, Industry · Terminated
Key facts
| NCT number | NCT01287741 |
|---|---|
| Title | A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA) |
| Official title | A Phase III, Multicenter, Open-Label Randomized Trial Comparing the Efficacy of GA101 (RO5072759) in Combination With CHOP (G-CHOP) Versus Rituximab and CHOP (R-CHOP) in Previously Untreated Patients With CD20-Positive Diffuse Large B-Cell Lymphoma (DLBCL) |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Collaborators | Fondazione Italiana Linfomi - ETS |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diffuse Large B-Cell Lymphoma |
| Intervention type | Drug |
| Interventions | Rituximab, Obinutuzumab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone |
| Enrollment | 1,418 |
| Start date | Jul 26, 2011 |
| Primary completion | Apr 29, 2016 |
| Completion | Jan 31, 2018 |
| First posted | Feb 1, 2011 |
| Last update posted | Apr 12, 2019 |
| Countries | Argentina, Australia, Austria, Brazil, Canada, China, Colombia, Czechia, Denmark, Germany, Hong Kong, Hungary and 17 more |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: